Today’s Stocks: Keryx Biopharmaceuticals Inc. (NASDAQ:KERX), Memorial Production Partners LP (NASDAQ:MEMP), Ironwood Pharmaceuticals, Inc. (NASDAQ:IRWD), Insmed Incorporated (NASDAQ:INSM), Molina Healthcare, Inc. (NYSE:MOH)

On 27 July, Keryx Biopharmaceuticals, Inc. (NASDAQ:KERX) announced the appointment of Scott A. Holmes to Chief Financial Officer effective immediately. Mr. Holmes will be responsible for Keryx’s finance function and will be a member of the company’s executive team. He will succeed James Oliviero whose planned departure was announced earlier this year. Mr. Oliviero will stay with the company through a transition period. Keryx Biopharmaceuticals Inc. (NASDAQ:KERX) belongs to Healthcare sector. Its weekly performance is -2.72%. On last trading day company shares ended up $7.51. Keryx Biopharmaceuticals Inc. (NASDAQ:KERX) distance from 50-day simple moving average (SMA50) is -21.69%.

Memorial Production Partners LP (NASDAQ:MEMP) reported Average daily production increased 10% to 247.8 MMcfe for the second quarter 2015, compared to 224.8 MMcfe for the second quarter 2014.Revolver availability of approximately $642 million as of July 31, 2015.Strong commodity hedge portfolio with 85% of current expected total production hedged in 2015, 84% in 2016, 70% in 2017, 64% in 2018 and 49% in 2019.Memorial Production Partners LP (NASDAQ:MEMP) shares decreased -19.59% in last trading session and ended the day at $7.51. MEMP Gross Margin is 68.70% and its return on assets is -1.60%. Memorial Production Partners LP (NASDAQ:MEMP) quarterly performance is -53.67%.

Ironwood Pharmaceuticals, Inc. (NASDAQ:IRWD) announced an agreement with Allergan plc for the U.S. co-promotion of VIBERZI™ (eluxadoline), Allergan’s new treatment for adults suffering from irritable bowel syndrome with diarrhea (IBS-D). On 05 August, Ironwood Pharmaceuticals, Inc. (NASDAQ:IRWD) shares moved up 0.94% and was closed at $10.72. IRWD EPS growth in last 5 year was 30.30%. Ironwood Pharmaceuticals, Inc. (NASDAQ:IRWD) year to date (YTD) performance is -30.03%.

Zacks downgraded shares of Insmed (NASDAQ:INSM) from a buy rating to a hold rating in a report issued on Tuesday, Analyst Ratings.Net reports. Insmed Incorporated (NASDAQ:INSM) ended the last trading day at $27.54. Company weekly volatility is calculated as 3.00% and price to cash ratio as 12.58. Insmed Incorporated (NASDAQ:INSM) showed a weekly performance of 2.53%.

On 3 August, Molina Healthcare, Inc. (NYSE:MOH) and Integral Health Plan, Inc. (d/b/a Integral Quality Care) announced that Molina Healthcare of Florida, Inc., a wholly owned subsidiary of Molina Healthcare Inc., has entered into a definitive agreement to acquire certain assets of the Medicaid business of Integral Quality Care. As a part of the transaction, Molina Healthcare of Florida will receive the right to assume Integral’s Medicaid members in the state of Florida, certain provider agreements, as well as other assets related to the operation of the Medicaid business. Molina Healthcare, Inc. (NYSE:MOH) shares moved up 2.44% in last trading session and ended the day at $77.24. MOH Gross Margin is 15.40% and its return on assets is 2.40%. Molina Healthcare, Inc. (NYSE:MOH) quarterly performance is 32.40%.

Leave a Reply

Your email address will not be published. Required fields are marked *